Skip to main content
. 2014 Mar 5;9(3):e90090. doi: 10.1371/journal.pone.0090090

Table 1. Characteristics of studies included in the meta-analysis.

Cancer type Year First author Country Ethnicity Source of control Genotyping method Polymorphism sites Cases Controls HWE
Cervical cancer
2009 Zucchini [52] Maton Grosso do Sul, Brazil African PB PCR-RFLP Fas -670A>G 91 176 0.545
2008 Tamandani [35] Northern India Asian HB PCR-RFLP Fas -670A>G 200 200 0.001
2008 Kang [4] Korea Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 154 160 0.264, 0.233, 0.327
2007 Ivansson [53] Sweden Caucasian PB TaqMan FasL -844C>T 1284 280 0.738
2006 Ueda [34] Japan Asian PB PCR-RFLP Fas -670A>G 83 95 0.172
2005 Zoodsma [5] Netherlands Caucasian PB TaqMan Fas -670A>G 670 607 0.274
2005 Sun [6] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 314 615 0.641, 0.304, 0.002
2005 Lai [7] China Asian HB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 318 318 0.736, 0.293, 0.920
2004 Dybikowska [8] Poland Caucasian PB PCR-RFLP Fas -670A>G 51 65 0.638
2003 Lai [9] China Asian HB PCR-RFLP Fas -670A>G 176 176 0.444
Gastric cancer
2012 Zhang [10] China Asian HB PCR-RFLP Fas -1377G>A, FasL -844C>T 375 496 0.064, 0.112
2011 Liu [12] China Asian PB PCR-RFLP Fas -1377G>A, FasL -844C>T 344 324 0.424, 0.083
2011 Kupcinskas [11] Mixed Caucasian PB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 114 238 0.199, 0.492, 0.715
2010 Zhou [13] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 262 524 0.133, 0.062, 0.899
2009 Wang [14] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 332 324 0.806, 0.870, 0.554
2008 Hsu [15] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 86 101 0.736, 0.914, 0.612
2006 Ikehara [54] Japan Asian PB PCR-CTPP Fas -670A>G 271 271 0.504
Breast cancer
2013 Hashemi [16] Iranian Caucasian PB T-ARMS-PCR Fas -670A>G, Fas -1377G>A, FasL -844C>T 134 152 0.045, 0.000, 0.183
2012 Wang [17] China Asian HB PCR-RFLP Fas -1377G>A, FasL -844C>T 375 496 0.064, 0.112
2012 Mahfoudh [18] Tunisia African PB PCR-RFLP FasL -844C>T 438 332 0.334
2007 Crew [19] America Caucasian PB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 1051 1101 0.754, 0.069, 0.602
2007 Zhang [20] China Asian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 836 834 0.797, 0.700, 0.110
2004 Krippl [21] Austria Caucasian PB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 499 495 0.924, 0.610, 0.418
Lung cancer
2008 Ter-Minassian [22] America Caucasian HB TaqMan Fas -1377G>A, FasL -844C>T 2174 1497 0.751, 0.254
2007 Gormus [23] Turkey Caucasian PB PCR-RFLP Fas -1377G>A 94 50 0.000
2006 Park [24] Korea Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 582 582 0.132, 0.024, 0.570
2005 Zhang [25] China Asian PB PCR-RFLP Fas -1377G>A, FasL -844C>T 1000 1270 0.046, 0.180
2003 Wang [55] America Mixed PB PCR-RFLP Fas -670A>G 68 74 0.481
Esophageal cancer
2011 Bye [32] Eastern or Western Cape African PB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 343 466 0.027, 0.670, 0.097
2011 Bye [32] Western Cape Mixed PB TaqMan Fas -670A>G, Fas -1377G>A, FasL -844C>T 195 420 0.170, 0.469, 0.741
2007 Jain [56] Northern India Asian PB PCR-RFLP Fas -670A>G 151 201 0.140
2003 Sun [57] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 588 648 0.130, 0.218, 0.061
Skin cancer
2010 Qureshi [58] Britain Caucasian PB NA Fas -670A>G, Fas -1377G>A, FasL -844C>T 779 842 0.210, 0.916, 0.427
2007 Zhang [59] Sweden Caucasian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 229 351 0.380, 0.009, 0.609
2006 Li [60] America Caucasian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 602 603 0.453, 0.951, 0.071
2001 Nelson [61] America Caucasian PB PCR-RFLP Fas -670A>G 776 435 0.117
Ovarian cancer
2012 Li [62] China Asian PB Allele-specific multiple ligase detection Fas -670A>G, Fas -1377G>A, FasL -844C>T 342 344 0.357, 0.972, 0.547
2007 Gormus [63] Turkey Caucasian PB PCR-RFLP Fas -1377G>A, FasL -844C>T 47 41 0.272, 0.678
2006 Ueda [34] Japan Asian PB PCR-RFLP Fas -670A>G 68 95 0.172
Prostate cancer
2012 Mandal [51] Northern India Asian HB PCR-RFLP Fas -670A>G, Fas -1377G>A 192 224 0.296, 0.035
2011 Shao [38] China Asian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 602 703 0.579, 0.099, 0.801
2008 Lima [64] Portugal Caucasian PB PCR-RFLP Fas -670A>G 657 247 0.365
Nasopharyngeal cancer
2010 Cao [65] China Asian PB PCR-RFLP Fas -1377G>A, FasL -844C>T 576 608 0.984, 0.015
2010 Zhu [66] China Asian PB PCR-RFLP Fas -670A>G 237 264 0.478
2006 Jrad [37] Tunisia African PB PCR-RFLP Fas -670A>G 170 224 0.585
Bladder cancer
2010 Gangwar [67] Northern India Asian PB PCR-RFLP Fas -670A>G 212 250 0.384
2006 Li [68] China Asian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 216 252 0.409, 0.970, 0.234
Other cancers
2010 Zhu [69] China Asian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 353 365 0.831, 0.777, 0.278
2010 Wang [70] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 294 333 0.034, 0.628, 0.271
2008 Yang [39] China Asian PB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 397 907 0.653, 0.062, 0.986
2007 Koshkina [71] America Mixed PB PCR-RFLP Fas -670A>G, Fas -1377G>A 123 510 0.786, 0.210
2007 Erdogan [72] Turkey Caucasian HB PCR-RFLP Fas -670A>G, FasL -844C>T 45 100 0.812, 0.727
2007 Hoa [33] America Mixed HB PCR-RFLP Fas -1377G>A 279 510 0.210
2007 Hob [33] America Mixed HB PCR-RFLP Fas -1377G>A 154 510 0.210
2006 Zhang [36] America Caucasian HB PCR-RFLP Fas -670A>G, Fas -1377G>A, FasL -844C>T 721 1234 0.481, 0.268, 0.411
2006 Ueda [34] Japan Asian PB PCR-RFLP Fas -670A>G 108 95 0.172

The Ho(a) investigated thyroid cancer, and the Ho(b) investigated salivary gland cancer.

PB: population based; HB: hospital based; T-ARMS-PCR:tetra-primeramplification refractory mutation system PCR; PCR-RFLP: restriction fragment length polymorphism; HWE: Hardy-Weinberg equilibrium.